Charfi N, Bouaziz A, Omri S, Gassara I, Feki R, Smaoui N
Can J Psychiatry. 2024; 69(9):717-726.
PMID: 38783828
PMC: 11351062.
DOI: 10.1177/07067437241253631.
Ben Ammar H, Hamdi G, Khelifa E, Khouadja S, Elhechmi Z
Psychiatr Q. 2020; 92(1):31-39.
PMID: 32440813
DOI: 10.1007/s11126-020-09755-0.
Weiner L, Doignon-Camus N, Bertschy G, Giersch A
Sci Rep. 2019; 9(1):14282.
PMID: 31582814
PMC: 6776521.
DOI: 10.1038/s41598-019-50818-5.
Kazemi R, Rostami R, Khomami S, Baghdadi G, Rezaei M, Hata M
Front Hum Neurosci. 2018; 12:356.
PMID: 30233346
PMC: 6135217.
DOI: 10.3389/fnhum.2018.00356.
Palazzo M, Arici C, Cremaschi L, Cristoffanini M, Dobrea C, DellOsso B
Clin Pract Epidemiol Ment Health. 2017; 13:71-81.
PMID: 28868081
PMC: 5564021.
DOI: 10.2174/1745017901713010071.
Neurocognitive functioning in individuals with bipolar disorder and their healthy siblings: A preliminary study.
Bauer I, Wu M, Frazier T, Mwangi B, Spiker D, Zunta-Soares G
J Affect Disord. 2016; 201:51-6.
PMID: 27179338
PMC: 4899217.
DOI: 10.1016/j.jad.2016.04.026.
Cognitive deficits in bipolar disorder: from acute episode to remission.
Volkert J, Schiele M, Kazmaier J, Glaser F, Zierhut K, Kopf J
Eur Arch Psychiatry Clin Neurosci. 2015; 266(3):225-37.
PMID: 26611783
DOI: 10.1007/s00406-015-0657-2.
Cognitive impairment in manic bipolar patients: important, understated, significant aspects.
Vrabie M, Marinescu V, Talasman A, Tautu O, Drima E, Miclutia I
Ann Gen Psychiatry. 2015; 14:41.
PMID: 26609314
PMC: 4659170.
DOI: 10.1186/s12991-015-0080-0.
Neuroprogression and Cognitive Functioning in Bipolar Disorder: A Systematic Review.
Cardoso T, Bauer I, Meyer T, Kapczinski F, Soares J
Curr Psychiatry Rep. 2015; 17(9):75.
PMID: 26257147
DOI: 10.1007/s11920-015-0605-x.
Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design.
Burdick K, Ketter T, Goldberg J, Calabrese J
J Clin Psychiatry. 2015; 76(3):e342-50.
PMID: 25830456
PMC: 4472380.
DOI: 10.4088/JCP.14cs09399.
The management of cognitive impairment in bipolar disorder: current status and perspectives.
Sanches M, Bauer I, Galvez J, Zunta-Soares G, Soares J
Am J Ther. 2014; 22(6):477-86.
PMID: 25383489
PMC: 4424179.
DOI: 10.1097/MJT.0000000000000120.
Neurocognitive profiles in treatment-resistant bipolar I and bipolar II disorder depression.
Kessler U, Schoeyen H, Andreassen O, Eide G, Hammar A, Malt U
BMC Psychiatry. 2013; 13:105.
PMID: 23557429
PMC: 3637095.
DOI: 10.1186/1471-244X-13-105.
Differential executive functioning performance by phase of bipolar disorder.
Ryan K, Vederman A, McFadden E, Weldon A, Kamali M, Langenecker S
Bipolar Disord. 2012; 14(5):527-36.
PMID: 22834461
PMC: 3773478.
DOI: 10.1111/j.1399-5618.2012.01032.x.
Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.
Burdick K, Braga R, Nnadi C, Shaya Y, Stearns W, Malhotra A
J Clin Psychiatry. 2011; 73(1):103-12.
PMID: 22152405
PMC: 4457389.
DOI: 10.4088/JCP.11m07299.
The characteristics of a discrete mood episode, neuro-cognitive impairment and re-hospitalization in bipolar disorder.
Levy B, Medina A, Manove E, Weiss R
J Psychiatr Res. 2011; 45(8):1048-54.
PMID: 21306735
PMC: 3194763.
DOI: 10.1016/j.jpsychires.2011.01.005.
A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state.
Kurtz M, Gerraty R
Neuropsychology. 2009; 23(5):551-62.
PMID: 19702409
PMC: 2804472.
DOI: 10.1037/a0016277.
Cognitive neuroscience and brain imaging in bipolar disorder.
Clark L, Sahakian B
Dialogues Clin Neurosci. 2008; 10(2):153-63.
PMID: 18689286
PMC: 3181872.
FAS and CFL forms of verbal fluency differ in difficulty: a meta-analytic study.
Barry D, Bates M, Labouvie E
Appl Neuropsychol. 2008; 15(2):97-106.
PMID: 18568601
PMC: 3085831.
DOI: 10.1080/09084280802083863.
Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy.
Burdick K, Braga R, Goldberg J, Malhotra A
CNS Drugs. 2007; 21(12):971-81.
PMID: 18020478
DOI: 10.2165/00023210-200721120-00002.
Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium.
Gualtieri C, Johnson L
MedGenMed. 2007; 8(3):46.
PMID: 17406176
PMC: 1781293.